Who owns ATARA BIOTHERAPEUTICS INC?
- Ticker: ATRA
- CUSIP Number: 046513206
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold ATARA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 442k | $2.1M | 0% | Mar 2026 |
|
| Mackenzie Financial | 314k | $1.5M | 435% | Mar 2026 |
|
| Vanguard Group | 226k | $4.1M | 11% | Dec 2025 |
|
| Vanguard Capital Management | 218k | $1.0M | 100% | Mar 2026 |
|
| Point72 Asset Management | 194k | $919k | 962% | Mar 2026 |
|
| Marshall Wace | 149k | $2.7M | 28% | Dec 2025 |
|
| Acadian Asset Management | 131k | $617k | 142% | Mar 2026 |
|
| EcoR1 Capital | 100k | $471k | -83% | Mar 2026 |
|
| BlackRock | 79k | $374k | 18% | Mar 2026 |
|
| Geode Capital Management | 66k | $313k | 6% | Mar 2026 |
|
| UBS Group | 50k | $237k | 3484% | Mar 2026 |
|
| Staley Capital Advisers | 50k | $237k | 0% | Mar 2026 |
|
| Millennium Management | 48k | $226k | 100% | Mar 2026 |
|
| Jane Street | 34k | $160k | 142% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 34k | $159k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 33k | $591k | 134% | Dec 2025 |
|
| Renaissance Technologies | 30k | $543k | 59% | Dec 2025 |
|
| State Street Corporation | 27k | $479k | 5% | Dec 2025 |
|
| Quadrature Capital | 20k | $368k | 100% | Dec 2025 |
|
| FMR | 17k | $310k | 0% | Dec 2025 |
|
| Susquehanna International | 14k | $254k | 100% | Dec 2025 |
|
| Northern Trust | 12k | $223k | 12% | Dec 2025 |
|
| Morgan Stanley | 9.2k | $43k | -43% | Mar 2026 |
|
| Royal Bank of Canada | 4.3k | $19k | 257% | Mar 2026 |
|
| Tower Research Capital | 1.7k | $31k | 408% | Dec 2025 |
|
| SBI Securities | 1.6k | $7.4k | 12% | Mar 2026 |
|
| Vanguard Global Advisers | 1.5k | $6.9k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 703.00 | $13k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 251.00 | $1.2k | 0% | Mar 2026 |
|
| Raiffeisen Bank International | 200.00 | $946.000000 | 100% | Mar 2026 |
|
| Banque Transatlantique SA | 176.00 | $905.995200 | 0% | Mar 2026 |
|
| Rhumbline Advisers | 175.00 | $826.997500 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 58.00 | $273.997800 | 26% | Mar 2026 |
|
| KERR FINANCIAL PLANNING Corp | 24.00 | $115.999200 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 10.00 | $180.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 8.00 | $38.000000 | 0% | Mar 2026 |
|
| Western Wealth Management | 1.00 | $5.000000 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $5.000000 | 100% | Mar 2026 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Globeflex Capital | Dec 2025 | 77k | $1.4M |
| Cambridge Investment Research Advisors | Dec 2025 | 23k | $414k |
| Citadel Advisors | Dec 2025 | 16k | $282k |
| Walleye Trading Advisors | Dec 2025 | 12k | $220k |
| Connor, Clark & Lunn Investment Management | Dec 2025 | 10k | $189k |
| Dimensional Fund Advisors | Dec 2025 | 10k | $181k |
| Private Wealth Asset Management | Dec 2025 | 900.00 | $16k |
| Jpmorgan Chase & Co | Sep 2025 | 216.00 | $3.1k |
| Federated Investors | Dec 2025 | 130.00 | $2.4k |